The two patients with AML‐NOS ASXL1+ share a severe dysgranulopoiesis in the bone marrow aspirate, and dysplasia in the other hematopoietic lines cannot be assessed because they are scarcely represented at diagnosis. Here, ASXL1 is linked to acute myeloid leukemia.